Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$78.93 - $95.84 $9.04 Million - $11 Million
114,500 New
114,500 $10.3 Million
Q1 2022

May 17, 2022

SELL
$23.7 - $41.39 $12.4 Million - $21.6 Million
-522,500 Reduced 82.08%
114,100 $4.72 Million
Q4 2021

Feb 15, 2022

BUY
$30.7 - $43.36 $10 Million - $14.2 Million
327,000 Added 105.62%
636,600 $24.1 Million
Q3 2021

Nov 16, 2021

BUY
$19.91 - $68.26 $5.45 Million - $18.7 Million
273,700 Added 762.4%
309,600 $10.2 Million
Q2 2021

Aug 16, 2021

BUY
$50.63 - $73.5 $931,592 - $1.35 Million
18,400 Added 105.14%
35,900 $2.42 Million
Q1 2021

May 18, 2021

SELL
$55.91 - $81.44 $4.72 Million - $6.88 Million
-84,500 Reduced 82.84%
17,500 $991,000
Q4 2020

Feb 17, 2021

SELL
$66.31 - $86.52 $2.06 Million - $2.68 Million
-31,000 Reduced 23.31%
102,000 $8.31 Million
Q3 2020

Nov 17, 2020

SELL
$68.34 - $85.84 $41,004 - $51,504
-600 Reduced 0.45%
133,000 $9.48 Million
Q2 2020

Aug 17, 2020

SELL
$49.87 - $98.69 $922,595 - $1.83 Million
-18,500 Reduced 12.16%
133,600 $11 Million
Q1 2020

May 15, 2020

BUY
$41.2 - $101.31 $2.77 Million - $6.81 Million
67,200 Added 79.15%
152,100 $8.95 Million
Q4 2019

Feb 14, 2020

BUY
$16.71 - $106.24 $666,729 - $4.24 Million
39,900 Added 88.67%
84,900 $8.78 Million
Q1 2019

May 16, 2019

BUY
$2.63 - $16.34 $118,350 - $735,300
45,000 New
45,000 $640,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.